Journalist Merrill Goozner questions FDA timidity: "FDA deputy Sandra Kweder testified on Capitol Hill (last) week that the agency needs more power to order label changes on drugs when the agency thinks stiffer warnings are warranted. Currently they negotiate with the companies, often leading to long delays before warnings get disseminated. It was a curious statement. Why doesn’t the agency simply say, 'Negotiation over. Change the label.' Memo to Kweder: You already have the power. What’s missing is the will to challenge a powerful industry with lots of friends in the White House and on Capitol Hill."
Posted by schwitz at March 7, 2005 08:05 AM